ViroPharma To Acquire Lev Pharmaceuticals
- Acquisition Adds Late Stage Product Targeting Life-threatening Hereditary Angioedema Disease with Limited Treatment Options - - Company to Host Conference Call at 10:30 A.M. Eastern Today to Discuss Transaction - EXTON, Pa., July 15 /PRNewswire-FirstCall/...ViroPharma Incorporated Reports First Quarter 2009 Financial Results
...APB 14-1 as described below; (2) amortization related to the acquisition of lev Pharmaceuticals and Vancocin, and step up in inventory related to purchase accounting arising from our acquisition of lev Pharmaceuticals, (3) stock compensation expenses, and (4) certain non-recur...ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
...rational: Closed on acquisition of lev Pharmaceuticals, Inc. (Lev) in October 2008; ...ur business to the transformational acquisition of lev Pharmaceuticals and the launch of Cinryze. As a r...arter of 2008 mainly related to the acquisition of lev ($380.2 million), offset slightly by operating cas...